• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 10
  • 7
  • 4
  • 1

PRICE

4
4
21
22

PUBLISHED

2
5
22
22

PRODUCT TYPE

18
4

Search "Regenerx Biopharmaceuticals Inc.-Therapeutic Competitors" returned 22 results.

PRODUCT TITLE

RegeneRx Biopharmaceuticals, Inc.

A textual analysis of the financial results for RegeneRx Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

December 2014

Opexa Therapeutics, Inc.

A textual analysis of the financial results for Opexa Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

December 2014
FROM

Oragenics, Inc.

A textual analysis of the financial results for Oragenics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

December 2014

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014’, provides an overview of the Venous Leg Ulcers...

February 2014
FROM

Epidermolysis Bullosa - Pipeline Review, H1 2014

Epidermolysis Bullosa - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epidermolysis Bullosa - Pipeline Review, H1 2014’, provides an overview of the Epidermolysis Bullosa’s therapeutic...

April 2014
FROM

Epidermolysis Bullosa - Pipeline Review, H2 2014

Epidermolysis Bullosa - Pipeline Review, H2 2014 Summary This, ‘Epidermolysis Bullosa - Pipeline Review, H2 2014’, provides an overview of the Epidermolysis Bullosa’s therapeutic pipeline. This report...

September 2014
FROM

Keratitis - Pipeline Review, H2 2014

Keratitis - Pipeline Review, H2 2014 Summary This, ‘Keratitis - Pipeline Review, H2 2014’, provides an overview of the Keratitis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Ibio, Incorporation

A textual analysis of the financial results for Ibio, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

December 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014’, provides an overview of the Peripheral...

August 2014
FROM

Stroke - Pipeline Review, H2 2014

Stroke - Pipeline Review, H2 2014 Summary This, ‘Stroke - Pipeline Review, H2 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive information on the...

October 2014
FROM

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2014

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2014 Summary This, ‘Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2014’, provides an overview of the Venous Leg Ulcers (Crural ulcer)’s...

July 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2014

Traumatic Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic...

April 2014
FROM

Diabetic Retinopathy - Pipeline Review, H1 2014

Diabetic Retinopathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H1 2014’, provides an overview of the Diabetic Retinopathy’s therapeutic pipeline. This...

March 2014
FROM

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2014

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2014’, provides an overview of the Keratoconjunctivitis...

March 2014
FROM

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2014

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2014 Summary This, ‘Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2014’, provides an overview of the Keratoconjunctivitis sicca...

September 2014
FROM

Multiple Sclerosis - Pipeline Review, H1 2014

Multiple Sclerosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This...

March 2014
FROM

Stroke - Pipeline Review, H1 2014

Stroke - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Stroke - Pipeline Review, H1 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Myocardial Infarction - Pipeline Review, H1 2014

Myocardial Infarction - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H1 2014’, provides an overview of the Myocardial Infarction’s therapeutic...

February 2014
FROM

Multiple Sclerosis - Pipeline Review, H2 2014

Multiple Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Multiple Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

September 2014
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.